Per Ljungman group
Per Ljungman heads a research group performing clinical studies with the aim to improve management of viral infections in allogeneic stem cell transplant patients.
The group focuses on immune responses to viral infections in severely immunocompromised studies
The group is involved in clinical trials with antiviral agents and vaccines. In collaboration with Professor Markus Maeurer and Professor Kalle Malmberg the group focuses on immune responses to viral infections in severely immunocompromised studies including studies of the NK-cell repertoire, T-cell responses, and detailed analysis of the B-cell response to the viral proteome.
|Andreas Björklund, PhD|
|Lena Perez-Bercoff, PhD student|
|Aditya Ambati, PhD student|